New in MMWR: Respiratory Syncytial Virus Vaccines, Arthritis Among Children, and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MMWR banner

July 21, 2023


The figure is a photo of a health care provider talking to a patient with text that reads “New MMWR on ACIP’s respiratory syncytial virus (RSV) vaccine recommendations.”

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

A single respiratory syncytial virus (RSV) vaccine dose demonstrated moderate to high efficacy in preventing symptomatic RSV-associated lower respiratory tract disease among adults aged 60 years and older.


Figure is a bar graph showing the percentage of U.S. children and adolescents aged 17 and younger who have experienced a specified stressful life event, by type of event and family income, based on data from the 2021 National Health Interview Survey.

PDF of this Issue (link).


The figure is a photo of a person sitting in a waiting room filling out a form.


This figure is an image of a microphone on a dark background with sound waves and the text “MMWR Weekly Briefing,” representing the MMWR podcast.

MMWR Weekly Briefing Podcast: Week of July 3

The latest MMWR Weekly Briefing is live. Topics include: birth defect-associated hospitalizations in the United States, the introduction of new vaccines worldwide, and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 

[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux